Acquisition/IPO

29 11, 2017

GE Healthcare Completes Acquisition of U College London-supported Bioprocessing Start-Up 

By |2017-11-29T15:15:55+00:00November 29th, 2017|Acquisition/IPO, Corporate, UK/England|0 Comments

GE Healthcare has completed the acquisition of Puridify, a UK-based bioprocessing start-up focused on a nanofiber-based platform purification technology for biopharmaceutical production, GE Healthcare announced on Nov. 28, 2017. As part of the acquisition, GE Healthcare will gain Puridify’s technology, FibroSelect, which is complementary to the bead resins and chromatography membranes used in downstream bioprocessing. [...]

29 11, 2017

University of Maryland start-up bought by Royal Phillips

By |2017-11-29T14:22:00+00:00November 29th, 2017|Acquisition/IPO, Corporate|0 Comments

A start-up company launched with technology licensed from the University of Maryland School of Medicine was bought by Royal Philips, the global health technology firm announced. Baltimore-based Analytical Informatics Inc. and its technology will be rolled into the Philips unit Philips Radiology Solutions, expanding its offerings more quickly. “Integrating Analytical Informatics’ software tools and applications [...]

7 09, 2017

U Arizona Startup SinfoníaRx Acquired by Health Care Tech Company, assisted by TLA

By |2017-09-07T12:12:01+00:00September 7th, 2017|Acquisition/IPO, Arizona|0 Comments

University of Arizona startup SinfoníaRx, a wholly owned subsidiary of Sinfonía HealthCare Corp., has been acquired by Tabula Rasa HealthCare (NASDAQ: TRHC), a public health care company that provides individualized, data-driven technology solutions. SinfoníaRx is a health care company whose mission is to provide the highest-quality solutions for health plans, patients and caregivers. Spun out as [...]

5 09, 2017

Oxford biotech startup Nightstar Therapeutics plans US NASDAQ float

By |2017-09-05T13:28:48+00:00September 5th, 2017|Acquisition/IPO, UK/England|0 Comments

Founded in 2014, the company has developed a technology that could cure blindness. Nightstar is the latest in a number of UK-based healthcare companies looking to US markets for IPOs. Investors in the US are said to have a better understanding of biotech, which leads them to value early-stage companies at higher amounts. Nightstar is [...]

11 05, 2017

Company with University of Kansas roots goes public on NASDAQ

By |2017-05-11T07:16:14+00:00May 11th, 2017|Acquisition/IPO, Kansas|0 Comments

Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and [...]

25 11, 2014

Cornell University’s Binoptics sold to Massachusetts company for $230M

By |2017-07-15T01:01:54+00:00November 25th, 2014|Acquisition/IPO, Massachusetts|0 Comments

Ithaca laser-technology company Binoptics is being bought by M/A-Com Technology Solutions of Lowell, Mass., for $230 million in cash, the company announced Wednesday. Binoptics, in business since 2000 using technology developed at Cornell University, develops and makes semicondutor microchip lasers for equipment in the data and telecommunications industries that use light energy rather than electricity. [...]

4 08, 2014

Finance Wales close to three profitable exits deals from firms into Technology Venture Investments portfolio

By |2017-07-15T01:46:08+00:00August 4th, 2014|Acquisition/IPO, Venture Capital, Wales|0 Comments

Finance Wales is close to three exits on companies backed by its technology-focused fund, including one via flotation. Director of Technology Venture investments Steve Smith said the £40m fund, which has backed around 40 mainly pre-revenue technology firms in Wales, was also working towards making its first co-investment(s) with the Welsh Government’s £100m Wales Life [...]

14 04, 2014

Cambridge University sells stake in pharma spin-out for $5.3M

By |2014-04-14T09:57:38+00:00April 14th, 2014|Acquisition/IPO, UK/England|0 Comments

Cambridge University has pocketed millions of pounds on a seed investment it made seven years ago in a company that makes “test tube patients” for drug research. The university made £3.17m, more than 30 times its original investment, after selling its stake in Horizon Discovery, which grows batches of cells containing tailored DNA. […]